Sign in
4/A

Changes in Ownership

BRAINSTORM CELL THERAPEUTICS INC. Filed Acc 0001144204-12-048073

Options or other derivatives

  • Chief Executive Officer acquired 70,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Harel Adrian · Chief Executive Officer

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2012-08-01 Grant or award : show line 1 in the form Stock Option (right to buy) +70,000 70,000 D
Loading xslF345X03/v322323_4a.xml…